The growth of healthcare industry and increasing investments in strengthening it have played a crucial role in the rising demand for circulating biomarkers. These biomarkers are extensively used for monitoring the progression of a disease, conducting a biopsy, and assessing the effectiveness of a treatment over a period of time. Biomarkers help in the accurate evaluation of patient’s prognosis, which is integral to adjusting or developing the treatment. Thus, circulating biomarkers are used for understanding the nature of immunology, cancer, neurology, cardiovascular, and metabolic disease. The Food and Drug Administration states that even a 10% advancement in understanding the positive or negative impact of drugs prior to clinical trials will result in savings worth US$100 mn of development expenditure for every drug.
Some of the key players in the global circulating biomarkers market are Affymetrix, Inc., Abbott Laboratories, Dickinson and Company, Becton, GE Healthcare, Agilent Technologies, Inc., Biocept, Inc., and Epigenomics AG. The research report offers an explanation of the competitive landscape present in the global market. It estimates the intensity of the competitive rivalry, business and marketing strategies, and research and development activities of these players. The report also documents the recent developments in the global circulating biomarkers market and analyzes their impact on the future of the overall market dynamics.
Download PDF brochure for this Report:
Transparency Market Research offers a comprehensive analysis of the global circulating biomarkers market. Its research report, “Circulating Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” provides a thorough examination of the drivers and restraints impacting the growth pattern of the global market. The researchers have collaborated the report using primary and secondary research methodologies to offer an insightful take on the evolution of the market. The report scrutinizes the segments of the market and studies the strengths, weaknesses, opportunities, and threats impacting them. The report is aimed at being a guiding document to its readers to make profitable business decisions.
In terms of regions, the global circulating biomarkers market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Currently, North America leads the global market with Europe in tow. The high prevalence of cancer across North America is the primary reason for the high uptake of circulating biomarkers in the region. The America Cancer Society stated that cancer has become the second most popular reason for death. Presently, every one in four deaths in the United States is due to cancer. Analysts predict that Asia Pacific circulating biomarkers market will also register a rapid growth rate as the development of targeted therapies and personalized medicines are gaining a sizeable momentum.
Browse Full Research Report on Circulating Biomarkers Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.